ImmunoGen Inc (NASDAQ:IMGN)

10.27
Delayed Data
As of Apr 20
 +0.03 / +0.29%
Today’s Change
3.59
Today|||52-Week Range
13.41
+60.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-71.4M-60.7M-78.9M-96.0M
 
 
 
 
 
Depreciation4.6M5.5M3.1M6.0M
 
 
 
 
 
Total Other Cash Flow29.2M15.9M5.3M20.1M
 
 
 
 
 
Funds From Operations-37.5M-39.4M-70.5M-69.9M
 
 
 
 
 
Funds From/For Other Operating Expenses16.1M15.9M13.2M-77.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-53.7M-55.3M-83.7M7.6M
 
 
 
 
 
 
InvestingCapital Expenditures-8.2M-7.4M-1.4M-1.1M
 
 
 
 
 
Other Investing - Uses-1.0K0.000.000.00
 
 
Net Cash Flow Investing-8.2M-7.4M-1.4M-1.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale9.1M4.4M0.00102.3M
 
 
 
 
Common Preferred Redeemed0.000.00--0.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.00194.1M--0.00
 
 
Other Uses - Financing0.00--0.001.7M
 
 
Net Cash Flow - Financing9.1M198.6M0.00100.6M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-52.7M135.8M-85.1M107.1M